SCHEMBL5437763

SCHEMBL5437763

Cc1cccc(N2CCN(Cc3ccc(-c4ccc(C(=O)NO)o4)cc3)CC2)c1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.51
ALDH1A1 P00352 4/20 0.51
POLB P06746 1/20 0.51
HPGD P15428 1/20 0.51
ALOX15 P16050 2/20 0.51
TSHR P16473 2/20 0.51
GAA P10253 1/20 0.50
SRPK1 Q96SB4 3/20 0.49
TP53 P04637 2/20 0.48
MAPK1 P28482 2/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
MAPT P10636 3/20 0.47
USP2 O75604 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HSD17B10 Q99714 1/20 0.47
HTR2A P28223 2/20 0.46
HTR2C P28335 2/20 0.46
SLC6A4 P31645 2/20 0.46
LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5445375 0.79 MAPT (0.59) KDM4EALDH1A1HPGDTSHRGAA
SCHEMBL5459011 0.78 HRH3 (0.64) KDM4EALDH1A1HPGDTSHRMAPK1
SCHEMBL5444736 0.74 MAPT (0.55) ALDH1A1HPGDTSHRMAPK1MEN1
Hydrochloric Acid SCHEMBL5987886 0.74 MEN1 (0.62) KDM4EALDH1A1POLBHPGDALOX15
SCHEMBL5449664 0.72 S1PR4 (0.48) KDM4EALDH1A1POLBHPGDMAPK1
SCHEMBL5456267 0.69 ALDH1A1 (0.52) ALDH1A1TSHRMAPK1MAPTUSP2
SCHEMBL5011344 0.68 HPGD (0.67) KDM4EALDH1A1POLBHPGDALOX15
SCHEMBL5452549 0.68 HDAC3 (0.56) KDM4EALDH1A1POLBHPGDGAA
SCHEMBL13087951 0.68 GAA (0.65) KDM4EALDH1A1POLBHPGDALOX15
SCHEMBL15938316 0.67 DRD4 (0.67) KDM4EALDH1A1POLBHPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 US disclosed
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 US disclosed
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 US disclosed
WO-2005040161-A1 BIARYL LINKED HYDROXAMATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S*BIO PTE LTD (SG) 2005-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications HDAC1, HDAC11, HDAC2 KDM4E 454/4885ALDH1A1 447/4885POLB 525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.